A 25-year-old man presented with abdominal pain and 15-kg weight loss over the course of 6 months. Computed tomography imaging showed hepatomegaly with diffuse heterogenous densities. A liver biopsy demonstrated intermediate to large cells within sinusoids with irregular nuclei, dispersed chromatin, occasional nucleoli, and scant cytoplasm (panel A; hematoxylin and eosin stain, original magnification ×400). The infiltrate was positive for CD45, CD79a, PAX5 (brown)/CD34 (red) double-stain (panel B; original magnification ×400), TdT, CD10, BCL6, MUM1, BCL2, MYC, and subset CD20 (panel C; original magnification ×400). Fluorescence in situ hybridization was negative for MYC, IGH-BCL2, or BCR-ABL1 rearrangements. Although the bone marrow was involved (panel D; hematoxylin and eosin stain, original magnification ×400), there was minimal blood involvement by flow cytometry. Bone marrow karyotype showed no evidence of hypodiploidy: 46,XY[cp15]. Next-generation sequencing of the marrow aspirate identified a TP53 p.R282W mutation (47.0% of reads) without copy number variants. Molecular testing on cultured fibroblasts confirmed the mutation as germline, indicative of Li-Fraumeni syndrome. A family history obtained through a translator revealed unknown cancers in the father (deceased aged 32 years) and paternal aunt.

This case illustrates precursor B lymphoblastic leukemia as the presenting neoplasm in Li-Fraumeni syndrome, mimicking intravascular diffuse large B-cell lymphoma. Although more than 90% of cases of precursor B lymphoblastic leukemia with low-hypodiploid cytogenetics will have mutations in TP53, almost half of which are germline, the hypodiploid karyotype was not identified in this case.

A 25-year-old man presented with abdominal pain and 15-kg weight loss over the course of 6 months. Computed tomography imaging showed hepatomegaly with diffuse heterogenous densities. A liver biopsy demonstrated intermediate to large cells within sinusoids with irregular nuclei, dispersed chromatin, occasional nucleoli, and scant cytoplasm (panel A; hematoxylin and eosin stain, original magnification ×400). The infiltrate was positive for CD45, CD79a, PAX5 (brown)/CD34 (red) double-stain (panel B; original magnification ×400), TdT, CD10, BCL6, MUM1, BCL2, MYC, and subset CD20 (panel C; original magnification ×400). Fluorescence in situ hybridization was negative for MYC, IGH-BCL2, or BCR-ABL1 rearrangements. Although the bone marrow was involved (panel D; hematoxylin and eosin stain, original magnification ×400), there was minimal blood involvement by flow cytometry. Bone marrow karyotype showed no evidence of hypodiploidy: 46,XY[cp15]. Next-generation sequencing of the marrow aspirate identified a TP53 p.R282W mutation (47.0% of reads) without copy number variants. Molecular testing on cultured fibroblasts confirmed the mutation as germline, indicative of Li-Fraumeni syndrome. A family history obtained through a translator revealed unknown cancers in the father (deceased aged 32 years) and paternal aunt.

This case illustrates precursor B lymphoblastic leukemia as the presenting neoplasm in Li-Fraumeni syndrome, mimicking intravascular diffuse large B-cell lymphoma. Although more than 90% of cases of precursor B lymphoblastic leukemia with low-hypodiploid cytogenetics will have mutations in TP53, almost half of which are germline, the hypodiploid karyotype was not identified in this case.

Close modal

For additional images, visit the ASH Image Bank, a reference and teaching tool that is continually updated with new atlas and case study images. For more information, visit http://imagebank.hematology.org.

Sign in via your Institution